Anticoagulant-induced oral bleeding by Victor Costa, Estela Kaminagakura

“…The final diagnosis was oral anticoagulant-induced lesions. Clinicians should be familiar with the side effects of anticoagulants, which are rare in the oral cavity, but can be life-threatening if diagnosed late or inaccurately, especially in older patients that often use many drugs. …”
Get full text

Hepatotoxicity of New Oral Anticoagulants by A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin

Subjects: Get full text

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY by D. A. Napalkov, A. A. Sokolova

“…Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including dabigatran, rivaroxaban and apixaban) is presented from the standpoint of safety. …”
Get full text

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION by A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko

Subjects: “…new oral anticoagulants…”
Get full text

NEW ORAL ANTICOAGULANTS IN THE THERAPY OF ANTIPHOSPHOLIPID SYNDROME by M. A. Satybaldyeva, T. M. Reshetnyak

Subjects: Get full text

Doctors’ Adherence to the Guidelines on the Oral Anticoagulants Usage by N. B. Perepech, I. E. Mikhailova, A. V. Tregubov

Subjects: “…oral anticoagulants…”
Get full text

COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS by V. A. Sulimov, D. A. Napalkov, A. A. Sokolova

“…Indirect comparisons of new oral anticoagulants are performed with focus on their safety. …”
Get full text

Sociodemographic and clinical profile of patients treated with oral anticoagulants by Thaisa Remigio Figueirêdo, Hirla Vanessa Soares de Araújo, Tâmara Silva, Maria Mariana Barros Melo da Silveira, Christefany Régia Brazc Costa, Simone Maria Muniz da Silva Bezerra

“…Objective: to describe the sociodemographic and clinical profile of patients treated with oral anticoagulants. Methods: cross-sectional study, conducted in an anticoagulation outpatient facility of a teaching hospital which is reference in cardiology. …”
Get full text

Sociodemographic and clinical profile of patients treated with oral anticoagulants by Thaisa Remigio Figueirêdo, Hirla Vanessa Soares de Araújo, Tâmara Silva, Maria Mariana Barros Melo da Silveira, Christefany Régia Brazc Costa, Simone Maria Muniz da Silva Bezerra

“…Objective: to describe the sociodemographic and clinical profile of patients treated with oral anticoagulants. Methods: cross-sectional study, conducted in an anticoagulation outpatient facility of a teaching hospital which is reference in cardiology. …”
Get full text

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA by D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev

Subjects: Get full text

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction by Z. D. Kobalava, A. A. Shavarov, M. V. Vatsik-Gorodetskaya

“…The doses of direct oral anticoagulants require adjustment for renal function. …”
Get full text

Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding by A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin

Subjects: “…direct oral anticoagulants…”
Get full text

THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY by A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev

Subjects: Get full text

CO29 | Emergency room physicians and oral anticoagulants related bleeding

“… Background: Emergency Room (ER) physicians are often the first to manage major bleeding related to oral anticoagulants. Methods: This was a prospective, observational, real-world study that began in January 2020 and ended in December 2022 to evaluate the first therapy perfomed by ER physicians for patients with bleeding related to oral anticoagulants. …”
Get full text

Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art by S. R. Gilyarevsky

Subjects: Get full text

Cost-effectiveness of direct oral anticoagulants in non-valvular atrial fibrillation by Inigo Gorostiza, Amaia Bilbao-Gonzalez, Javier Mar

“…Results: A total of 10,843 new users of oral anticoagulants with a mean follow-up of 4.1 years were included. …”
Get full text

DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS by S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov

“…The opinion is expressed in some  domestic publications that  rivaroxaban has  the  most  favorable profile of drug  interaction in comparison with other new oral anticoagulants (NOAC). The basis for such judgments is the summary table of drug interaction from the Guidelines of the European Heart Rhythm Association 2015 on the use of NOAC in patients with non-valvular atrial fibrillation.The paper discusses the issue that the abovementioned table contains some incorrect qualitative statements and quantitative data inconsistent with primary source  of information of NOAC drug interactions, and provides the updated and extended information on changes in NOAC plasma concentrations when  co-administered with drugs from the other  groups. …”
Get full text

Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants by A. D. Aga, A. A. Sokolova, D. A. Napalkov

Subjects: Get full text

The use of oral anticoagulants in patients with atrial fibrillation: cohort study data by O. V. Gaisenok, A. S. Leonov

Subjects: Get full text

DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT by D. А. Napalkov, A. A. Sokolova, V. V. Fomin

Subjects: “…new oral anticoagulants…”
Get full text